A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Clinical trial NCT02712112 · COMPLETED
Trial details
- NCT number
- NCT02712112
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-16
- Primary completion
- 2019-06-15
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.